Great Robotic Liver Surgery Masterclass at Orsi Academy/Belgium.
Thank you @IswantoSucandy, Fabrizio DiBendetto and Mathieu D’Hont!
Primera reunión académica multidisciplinaria en formato Journal Club del comité de Oncología Digestiva del Instituto Nacional del Cáncer (INCancer). Cirujanos, Oncólogos Medicos, Radioterapeutas, Endoscopia terapéutica, becados de sub especialidad reunidos. Muy productiva discusión.
Happy to share our first publication as Latin American Collaborative Sarcoma study group (LATAMSARC). Significant number of patients for our region!
Nicolas Devaud, MD retweeted
Variability in treatment approaches, outcomes, and recurrence patterns... sciencedirect.com/science/ar… @TARPSWG @ctosociety @SMEOMX @devaud_nicolas @sarresurgeon @DrPaulAdriazola @SelnetH2020 @SoMe4sarcoma #retroperitonealsarccoma #SARCOMA
Muchas gracias por la invitación @sarresurgeon – at Lo Barnechea, Chile
Listos para el 3° #webinar de #sarcoma #retroperitoneal: tratamiento #multidisciplinario 🔪💊☢️
Panel de expertas nacionales 🇲🇽 @ABCcentromedico @incanMX e invitado internacional 🇨🇱 @devaud_nicolas
Jue 16 Nov, 8pm CDMX
Registro gratuito ➡️ us06web.zoom.us/webinar/regi…
Aval @amcgmx
Nicolas Devaud, MD retweeted
Toronto fellows past and present representing at @ctosociety @homeofguinness
Nicolas Devaud, MD retweeted
Congrats @sarresurgeon @DorianGarciaMD @devaud_nicolas and welcome LATAMSARC collaborative! @TARPSWG @SoMe4sarcoma
Congratulations Dr. Sarre @sarresurgeon on this very important work -proud to work with you @UofTSurgOnc. Come check out her poster! @ctosociety
Nicolas Devaud, MD retweeted
@TARPSG dinner at Clontarf Castle Hotel in beautiful Dublin. @mylessmith giving the welcome to the group! Lots of fun and engagements!
Nicolas Devaud, MD retweeted
🆕Review - free to read and download
Complex Vascular Resections for Retroperitoneal Soft Tissue #Sarcoma
by Nicolas A. Devaud, Jean M. Butte et al
➡️mdpi.com/1718-7729/30/3/266
Nicolas Devaud, MD retweeted
Replying to @devaud_nicolas @Seanpcleary @ZhiVenFongMD @AmrAliRagab @HopSTranCao @cutitoutPODCAS1 @shimulshah73 @mj_pucci @AmarGupta_MD @HPB_Knife @NirajGusani @rachnatshroff
Gem Cis abraxane was based on a positive phase II study. However, recent SWOG 1815 randomized phase III presented at GI @ASCO was negative. There were subsets that benefitted, but not powered for. So for advanced BTC, Gem Cis Durva is what most consider standard (TOPAZ study).
Hill climbing=life lessons for the kids. Small steps, one after the other to get to the top, never look back! – at Lo Barnechea, Chile
RP DD-LPS… Maybe aorta needs to be reconstructed drive.google.com/file/d/1X20… #sarcoma #oncovascular




































